EMD is an actively-managed dollar-denominated emerging market debt leveraged CEF. Each adjective has important implications for shareholders. As EMD is actively-managed, performance is somewhat ...

Western Asset Emerging Markets Debt Fund is rated a hold due to limited appeal at current valuations and inconsistent dividend coverage. EMD's 10.7% yield is attractive, but payout sustainability is ...

Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis Cladribine capsules has ...

The first reports of comet 3I/ATLAS were made on July 1, 2025, by the ATLAS (Asteroid Terrestrial-impact Last Alert System) telescope in Chile. This comet caught the world's attention since it was the ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

In early July, astronomers spotted a mysterious object, later dubbed 3I/ATLAS after it was confirmed to be the third-ever interstellar visitor cruising through our solar system. Last week, the object, ...

A Harvard University professor has said 3I/ATLAS, a comet shrouded in controversy, experienced a sudden "nongravitational" acceleration while passing around the sun, which he believes adds to other ...

Merck KGaA’s U.S. arm EMD Serono is joining President Donald Trump’s most-favored nation drug pricing push with an agreement to sell its fertility therapies at a sharp discount through the ...

On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the ...

President Donald Trump made an announcement Thursday from the Oval Office that EMD Serono will reduce the cost of fertility medication in effort to help make IVF more affordable. Watch Trump’s remarks ...

EMD Serono also entered an agreement with the U.S. secretary of commerce to exclude its pharmaceutical products and ingredients from Section 232 tariffs. To further expand therapeutic options for ...

WASHINGTON—President Trump said he reached an agreement with a drugmaker to lower the cost of medications used in a common fertility treatment, addressing an issue he raised on the campaign trail but ...